Table 4 Univariate and multivariant analysis to identify variables associated with 3rd-time injection completion rate
Successful 3rd-time injection completion rate | ||||
|---|---|---|---|---|
Univariant aOR (95% CI) | p value | Multivariant aOR (95% CI) | p value | |
Age | 1.04 (1.03–1.06) | < 0.001 | 1.04 (1.03–1.06) | < 0.001 |
Sex (Female) | 1.38 (0.99–1.93) | 0.053 | ||
BMI | 1.06 (1.01–1.11) | 0.012 | 0.99 (0.94–1.04) | 0.092 |
Hypertension | 7.25 (0.35–35.98) | 0.146 | ||
T2DM | 7.10 (0.97–51.91) | 0.530 | ||
Abnormal ALT | 1.55 (0.974–2.47) | 0.065 | ||
Vaccination type (0–1–2-months vs. 0–1–6-months) | 1.56 (1.112–2.20) | 0.010 | 1.68 (1.19–2.39) | 0.003 |